2023 US Health Services
Financial Strength Rankings using Artificial Intelligence
| Top rated | 24 of 97 |
| Best rating | 513 % |
| Worst rating | -1,847 % |
| New companies | 10 |
| Negative Economic Capital Ratio | 27 of 97 |
Financial Strength Rankings using Artificial Intelligence
| Top rated | 24 of 97 |
| Best rating | 513 % |
| Worst rating | -1,847 % |
| New companies | 10 |
| Negative Economic Capital Ratio | 27 of 97 |
Biorestorative Therapies Inc climbed 41 positions from 64 to 23 due to its excellent Assets, Current.Teladoc Health Inc lost 80 positions from 2 to 82 due to its bad Goodwill Impairment Loss.American Oncology Network Inc entered the 2023 ranking at rank 1, making it the best newcomer.
| Revenues | 207 B |
| Assets | 257 B |
| Expenses | 216 B |
| Stockholders Equity | 128 B |
| Unprofitable Companies | 62 of 97 |
The Feature Distribution shows the main industry variables and the distribution of their impact on financial strength. The more important a variable, the broader the distribution. As the effects are calculated relative to the industry average, half of the companies have a positive effect (green) and half have a negative effect (red).
The Regression compares the forecasted company valuation with the observed stock market values. A positive correlation suggests that the model effectively explains market prices.

This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai